
About
LxBio AB is a CRO in Lisboa, Portugal that supports therapeutic and research antibody discovery, optimization, production, characterization, and cell line development. It serves clients developing antibody programs with single B-cell technology, phage display, and antibody engineering workflows.
Services
Single B Cell Antibody Discovery
Screens and isolates individual antigen-specific B cells to identify high-specificity, high-affinity antibody candidates.
Phage Display Antibody Discovery
Provides phage display-based discovery from immunization through top-clone selection, including library creation and multiple antibody formats.
Antibody Optimization
Improves antibody affinity, specificity, stability, humanization, and effector function for therapeutic or diagnostic use.
Affinity Maturation
Uses library construction and random mutagenesis to generate higher-affinity antibody candidates, with cloning, expression, purification, and quality assessment.
Antibody Conversion
Humanizes murine or other species-derived antibodies and reformats antibodies without compromising binding or function.
Effector Function Optimization
Engineers Fc regions to enhance antibody effector activity.
Antibody Production
Provides gene-to-antibody and small-scale research-grade antibody production with purification and quality assessment.
Protein production
Single Cell Line Development
Develops stable antibody-producing cell lines using single-cell isolation, real-time productivity assessment, and clone selection.
Cell line development
4 more services
- Antibody Characterization
- Binding Affinity and Specificity Analysis
- Developability Assessment
- Functional Characterization
- Turnaround
- Sample to sequence in weeks
- Cell line development timeline to just 3 weeks
- What to send
- Amino acid or nucleotide sequence
- Antigen-specific B cells
- Animal immunization for phage display
Capabilities
- Assays and studies
- Antibodies
- Phage display
- Rodent models
- In vivo
- CHO
- Single B-cell screening
14 more
- High-resolution functional assays
- SPR
- Epitope binning
- Epitope mapping
- SDS-PAGE
- ELISA
- SEC-HPLC
- DSC
- DLS
- MS
- ADCC assays
- CDC assays
- PK studies
- Stability studies
- Scale and capacity
- Yields ranging from a few milligrams to hundreds of milligrams
- Cell line development timeline to just 3 weeks
- Therapeutic areas
- Therapeutic antibodies
- Diagnostic antibodies
- Research antibodies
Instruments and platforms
- Surface Plasmon Resonance (SPR)
Modalities and species
- Modalities
- Antibody
- Species and models
- Human
- Rabbit
- Rat
- Chicken
- Camelid
- Sheep
- Monkey
- CHO cells
Details
- Type
- CRO
- Based in
- Lisbon, Portugal
- Sites
- Lisboa, Portugal